LFG
ADMA icon

Larson Financial Group’s ADMA Biologics ADMA Stock Holding History

Larson Financial Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Buy
1,773
+1,081
+156% +$9.86K ﹤0.01% 2179
2026
Q1 		$6.24K Sell
692
-2,570
-79% -$40.6K ﹤0.01% 2490
2025
Q4 		$59.5K Buy
3,262
+2,876
+745% +$48.5K ﹤0.01% 1152
2025
Q3 		$5.66K Sell
386
-12
-3% -$206 ﹤0.01% 2313
2025
Q2 		$7.25K Buy
+398
New +$8.12K ﹤0.01% 1953
2024
Q4 		– Sell
-1,527
Closed -$30.5K – 2766
2024
Q3 		$30.5K Buy
+1,527
New +$23.7K ﹤0.01% 1063

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Larson Financial Group's ADMA Position: Q2 2026 in Review

Larson Financial Group increased its ADMA Biologics (ADMA) stake by 156% in Q2 2026, buying an estimated $9.86K and bringing the position to 1,773 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2179.

Larson Financial Group first reported a position in ADMA in Q3 2024 and has held it in 6 quarters since. The position peaked at $59.5K in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Larson Financial Group held 1,773 shares of ADMA Biologics worth $14.8K as of Q2 2026.
  • Larson Financial Group bought 1,081 ADMA Biologics shares in Q2 2026, an estimated $9.86K.
  • ADMA Biologics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2179 holding.
  • Larson Financial Group first reported a position in ADMA Biologics in Q3 2024 and has held it in 6 quarters since.
  • Larson Financial Group's ADMA Biologics position peaked at $59.5K in Q4 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.